IECM
LLY icon

Intrinsic Edge Capital Management’s Eli Lilly LLY Stock Holding History

Intrinsic Edge Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$3.66M – 172
2022
Q4 		$3.66M Buy
+10,000
New +$3.55M 0.36% 98

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Intrinsic Edge Capital Management's LLY Position: Q1 2023 in Review

Intrinsic Edge Capital Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 10,000 shares — an estimated $3.66M sold.

Intrinsic Edge Capital Management first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $3.66M in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Intrinsic Edge Capital Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 10,000 Eli Lilly shares in Q1 2023, an estimated $3.66M.
  • Intrinsic Edge Capital Management first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's Eli Lilly position peaked at $3.66M in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2023, filed 15 May 2023.